Search

Your search keyword '"Meneveau N"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Meneveau N" Remove constraint Author: "Meneveau N" Topic business.industry Remove constraint Topic: business.industry
19 results on '"Meneveau N"'

Search Results

1. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

2. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

3. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

4. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

5. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

6. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions

7. Ezetimibe added to statin therapy after acute coronary syndromes

8. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

9. Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International CLARIFY registry

10. Oral Apixaban for the Treatment of Acute Venous Thromboembolism

11. Apixaban for extended treatment of venous thromboembolism

12. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial

13. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

14. Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction

15. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

16. Incomplete echocardiographic recovery at 6months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial

17. French Intensive Care Society, International congress – Réanimation 2016

18. Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

19. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

Catalog

Books, media, physical & digital resources